Our studies in cancer biology and pediatric oncology are focused on cellular plasticity, a phenomenon that relates both to the fundamental mechanisms of cancer pathogenesis and to the development of improved rational therapies. Detailed information about our research is available at http://alexkentsis.net.
Alex Kentsis, MD, PhD
Research FocusCancer biologist and pediatric oncologist Alex Kentsis leads research in the functional proteomics and genomic plasticity of refractory childhood cancers.
- MD, Mount Sinai School of Medicine
- PhD, New York University
- Henssen A, Henaff E, Jiang E, Eisenberg A, Carson J, Villasante C, Roy M, Still E, Burns M, Gandara J, Feschotte C, Mason C, Kentsis A. Genomic DNA transposition induced by human PGBD5. eLife, 2015.
- Dhabaria A, Cifani P, Reed C, Steen H, Kentsis A. A High-Efficiency Cellular Extraction System for Biological Proteomics. J Proteome Res, 2015.
- Physician-Scientist Award, American Society for Clinical Investigation (2015)
- Scholar Award, American Society of Hematology (2014)
- Career Award for Medical Scientists, Burroughs Wellcome Fund (2013)
- Young Investigator Award, American Society for Pediatric Hematology/Oncology (2013)
- Young Investigator Award, Alliance for Clinical Trials in Oncology (2012)
- Research Award, Society of Pediatric Research (2009)
- Pediatric Hematology-Oncology Fellowship, Dana-Farber Cancer Institute and Boston Children’s Hospital, Harvard Medical School
- Residency in Pediatrics, Boston Children’s Hospital, Harvard Medical School
- MD and PhD, Mount Sinai School of Medicine and New York University
- AB and SM, University of Chicago